Blood microperfusion to skin by Shilajit
US11077045B2 · kind B2 · utility
3Cited by
0References
9Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jun 26, 2018 |
| Grant date | Aug 3, 2021 |
| Priority date | — |
| Expiry date | Jun 26, 2038 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K2800/92
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Methods of using Shilajit or its individual components, or a combination of two or more of these components, to improve skin microperfusion, to upregulate ECM related genes in the skin, to increase endothelial cell migration and growth of blood vessels, and thus to improve skin health are presented herein.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.